Search

Your search keyword '"Gale AN"' showing total 2,893 results

Search Constraints

Start Over You searched for: Author "Gale AN" Remove constraint Author: "Gale AN" Database ScienceDirect Remove constraint Database: ScienceDirect
2,893 results on '"Gale AN"'

Search Results

1. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

5. Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study

8. SGLT2-Inhibition in Patients With Alport Syndrome

11. The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial

15. A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

17. Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study

18. Rapid Acute Coronary Syndrome Evaluation Over One Hour With High-Sensitivity Cardiac Troponin I: A United States-Based Stepped-Wedge, Randomized Trial

25. Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB study

27. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

30. SHIELD: Skull-shaped hemispheric implants enabling large-scale electrophysiology datasets in the mouse brain

34. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

36. Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemia

38. Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML

41. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

44. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort

45. Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial

48. Novel AAV variants with improved tropism for human Schwann cells

49. Association of antenatal or neonatal SARS-COV-2 exposure with developmental and respiratory outcomes, and healthcare usage in early childhood: a national prospective cohort study

Catalog

Books, media, physical & digital resources